CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Europace (London, England) England), 2021-05, Vol.23 (Supplement_3)
Hauptverfasser:	Sadredini, M, Manotheepan, R, Haugsten Hansen, M, Frisk, M, Louch, WE, Lehnart, SE, Anderson, ME, Sjaastad, I, Stokke, MK
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue	Supplement_3
container_start_page
container_title	Europace (London, England)
container_volume	23
creator	Sadredini, M Manotheepan, R Haugsten Hansen, M Frisk, M Louch, WE Lehnart, SE Anderson, ME Sjaastad, I Stokke, MK
description
doi_str_mv	10.1093/europace/euab116.564
format	Article
fullrecord	<record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_europace_euab116_564</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_europace_euab116_564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c914-62423ac4698cffb4611278e71771e113bd004ed52b11baca4ba138f7c8a685323</originalsourceid><addsrcrecordid>eNo1kN1Kw0AQhRdRsFbfwIt9gdSd3c3PXkrxp1jxpteGyWTSRJImbBIhb--K9Wo-GM6B8wlxD2oDypkHnn0_IHEALACSTZzYC7GC2OhIK6cvAyvnohi0uxY34_illEq1i1fic4vvb7udxFGinGr2OPA8NSQn9EeeZHOShBNT3bfYNSf2x_Ab-nbpej_Ugb_5NPmG5hZ9yFC9EPqyCV3LwBJuxVWF7ch357sWh-enw_Y12n-87LaP-4gc2CjRVhskm7iMqqqwCYBOM04hTYEBTFEqZbmMdRhXIKEtEExWpZRhkoWRZi3sXy35fhw9V_ngmw79koPKfxXl_4rys6I8KDI_Lm1e-g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Sadredini, M ; Manotheepan, R ; Haugsten Hansen, M ; Frisk, M ; Louch, WE ; Lehnart, SE ; Anderson, ME ; Sjaastad, I ; Stokke, MK</creator><creatorcontrib>Sadredini, M ; Manotheepan, R ; Haugsten Hansen, M ; Frisk, M ; Louch, WE ; Lehnart, SE ; Anderson, ME ; Sjaastad, I ; Stokke, MK</creatorcontrib><identifier>ISSN: 1099-5129</identifier><identifier>EISSN: 1532-2092</identifier><identifier>DOI: 10.1093/europace/euab116.564</identifier><language>eng</language><ispartof>Europace (London, England), 2021-05, Vol.23 (Supplement_3)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Sadredini, M</creatorcontrib><creatorcontrib>Manotheepan, R</creatorcontrib><creatorcontrib>Haugsten Hansen, M</creatorcontrib><creatorcontrib>Frisk, M</creatorcontrib><creatorcontrib>Louch, WE</creatorcontrib><creatorcontrib>Lehnart, SE</creatorcontrib><creatorcontrib>Anderson, ME</creatorcontrib><creatorcontrib>Sjaastad, I</creatorcontrib><creatorcontrib>Stokke, MK</creatorcontrib><title>CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1</title><title>Europace (London, England)</title><issn>1099-5129</issn><issn>1532-2092</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo1kN1Kw0AQhRdRsFbfwIt9gdSd3c3PXkrxp1jxpteGyWTSRJImbBIhb--K9Wo-GM6B8wlxD2oDypkHnn0_IHEALACSTZzYC7GC2OhIK6cvAyvnohi0uxY34_illEq1i1fic4vvb7udxFGinGr2OPA8NSQn9EeeZHOShBNT3bfYNSf2x_Ab-nbpej_Ugb_5NPmG5hZ9yFC9EPqyCV3LwBJuxVWF7ch357sWh-enw_Y12n-87LaP-4gc2CjRVhskm7iMqqqwCYBOM04hTYEBTFEqZbmMdRhXIKEtEExWpZRhkoWRZi3sXy35fhw9V_ngmw79koPKfxXl_4rys6I8KDI_Lm1e-g</recordid><startdate>20210524</startdate><enddate>20210524</enddate><creator>Sadredini, M</creator><creator>Manotheepan, R</creator><creator>Haugsten Hansen, M</creator><creator>Frisk, M</creator><creator>Louch, WE</creator><creator>Lehnart, SE</creator><creator>Anderson, ME</creator><creator>Sjaastad, I</creator><creator>Stokke, MK</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20210524</creationdate><title>CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1</title><author>Sadredini, M ; Manotheepan, R ; Haugsten Hansen, M ; Frisk, M ; Louch, WE ; Lehnart, SE ; Anderson, ME ; Sjaastad, I ; Stokke, MK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c914-62423ac4698cffb4611278e71771e113bd004ed52b11baca4ba138f7c8a685323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sadredini, M</creatorcontrib><creatorcontrib>Manotheepan, R</creatorcontrib><creatorcontrib>Haugsten Hansen, M</creatorcontrib><creatorcontrib>Frisk, M</creatorcontrib><creatorcontrib>Louch, WE</creatorcontrib><creatorcontrib>Lehnart, SE</creatorcontrib><creatorcontrib>Anderson, ME</creatorcontrib><creatorcontrib>Sjaastad, I</creatorcontrib><creatorcontrib>Stokke, MK</creatorcontrib><collection>CrossRef</collection><jtitle>Europace (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sadredini, M</au><au>Manotheepan, R</au><au>Haugsten Hansen, M</au><au>Frisk, M</au><au>Louch, WE</au><au>Lehnart, SE</au><au>Anderson, ME</au><au>Sjaastad, I</au><au>Stokke, MK</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1</atitle><jtitle>Europace (London, England)</jtitle><date>2021-05-24</date><risdate>2021</risdate><volume>23</volume><issue>Supplement_3</issue><issn>1099-5129</issn><eissn>1532-2092</eissn><doi>10.1093/europace/euab116.564</doi><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1099-5129
ispartof	Europace (London, England), 2021-05, Vol.23 (Supplement_3)
issn	1099-5129 1532-2092
language	eng
recordid	cdi_crossref_primary_10_1093_europace_euab116_564
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford Journals Open Access Collection; PubMed Central; Alma/SFX Local Collection
title	CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T13%3A25%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CaMKII%20as%20a%20therapeutic%20target%20in%20catecholaminergic%20polymorphic%20ventricular%20tachycardia%20type%201&rft.jtitle=Europace%20(London,%20England)&rft.au=Sadredini,%20M&rft.date=2021-05-24&rft.volume=23&rft.issue=Supplement_3&rft.issn=1099-5129&rft.eissn=1532-2092&rft_id=info:doi/10.1093/europace/euab116.564&rft_dat=%3Ccrossref%3E10_1093_europace_euab116_564%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true